Request Deal Involvement
ANI Pharmaceuticals completed the acquisition of Alimera Sciences for $453m.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
pr advisors
Longacre Square Partners
legal advisors to financial advisors
Ropes & Gray
legal advisors
Cooley
financial advisors
Centerview Partners
financial advisors
Perella Weinberg Partners
pr advisors
Core IR
legal advisors
DLA Piper
pr advisors
In-Site Communications
financial advisors
Guggenheim Partners
financial advisors
Raymond James
legal advisors
Hughes Hubbard & Reed
legal advisors
Perez Llorca
or
Principals
target
ALIMERA SCIENCES INC
bidder
ANI PHARMACEUTICALS
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite